1. Report Overview
1.1 Overview of the World Market for Neuromodulation Devices
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by this Analysis
1.5 Who is this Study for?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to Neuromodulation
2.1 Neuromodulation
2.2 Techniques Used in Neuromodulation
2.2.1 Electrical Stimulation Techniques
2.2.1.1 Brain and Spinal Cord Therapies
2.2.1.2 Cranial Nerve Stimulation
2.2.1.3 Functional Electrical Stimulation
2.2.2 Pharmacological Therapy
2.3 Application of Neuromodulation
2.3.1 Pain
2.3.2 Depression
2.3.3 Epilepsy
2.3.4 Faecal and Urinary Incontinence
2.3.5 Hearing Disorders – Profound Deafness
2.3.6 Cardiovascular Diseases – Arrhythmia and Angina
2.3.7 Neurodegenerative Diseases – Parkinson’s Disease
3. The World Neuromodulation Devices Market, 2014-2025
3.1 Global Neuromodulation Devices Market: 2014
3.2 Global Neuromodulation Devices Forecast: 2014-2025
3.3 Neuromodulation Devices: Industry Trends, 2014-2025
3.3.1 Industry Trends – Ageing Population
3.3.2 Industry Trends – Personalised Healthcare
3.3.3 Industry Trends – Stricter Regulations
3.3.4 Industry Trends – Economic Troubles
3.3.5 Industry Trends – Mergers and Acquisitions
4. Neuromodulation Devices: Outlook for Market Segments, 2014-2025
4.1 Spinal Cord Stimulation (SCS)
4.1.1 SCS Market Forecast: 2014-2025
4.1.2 SCS Market Trends: 2014-2025
4.2 Deep Brain Stimulation (DBS)
4.2.1 DBS Market Forecast: 2014-2025
4.2.2 DBS Market Trends: 2014-2025
4.3 Vagus Nerve Stimulation (VNS)
4.3.1 VNS Market Forecast: 2014-2025
4.3.2 VNS Market Trends: 2014-2025
4.4 Sacral Nerve Stimulation (SNS)
4.4.1 SNS Market Forecast: 2014-2025
4.4.2 SNS Market Trends: 2014-2025
4.5 Other Neuromodulation Techniques
4.5.1 Cochlear Implants
4.5.2 Transmagnetic Stimulation (TMS)
4.5.3 Transcranial Direct Current Stimulation (tDCS)
4.5.4 Ultrasonic Neuromodulation
4.5.5 Other Neuromodulation Techniques Forecast: 2014-2025
5. Leading National Markets, 2014-2025
5.1 Neuromodulation Devices: Leading Markets, 2014
5.2 The US Neuromodulation Devices Market: 2014-2025
5.2.1The US Neuromodulation Devices Market: 2014
5.2.2 The US Neuromodulation Devices Market Forecast: 2014-2025
5.2.3 The Effects of Regulations on the US Market
5.3 The Japanese Neuromodulation Devices Market: 2014-2025
5.3.1 The Japanese Neuromodulation Devices Market: 2014
5.3.2 The Japanese Neuromodulation Devices Market Forecast: 2014-2025
5.3.3 The Effects of Regulations on the Japanese Market
5.4 The European Neuromodulation Devices Market: 2014-2025
5.4.1 The European Neuromodulation Devices Market: 2014
5.4.2 The European Neuromodulation Devices Market Forecast: 2014-2025
5.5 The German Neuromodulation Devices Market: 2014-2025
5.5.1 The German Neuromodulation Devices Market: 2014
5.5.2 The German Neuromodulation Devices Market Forecast: 2014-2025
5.6 The French Neuromodulation Devices Market: 2014-2025
5.6.1 The French Neuromodulation Devices Market: 2014
5.6.2 The French Neuromodulation Devices Market Forecast: 2014-2025
5.6.3 The French Neuromodulation Devices Market – the Economy and its Implications
5.7 The Italian Neuromodulation Devices Market: 2014-2025
5.7.1 The Italian Neuromodulation Devices Market: 2014
5.7.2 The Italian Neuromodulation Devices Market Forecast: 2014-2025
5.7.3 The Italian Neuromodulation Devices Market Outlook
5.8 The UK Neuromodulation Devices Market: 2014-2025
5.8.1 The UK Neuromodulation Devices Market: 2014
5.8.2 The UK Neuromodulation Devices Market Forecast: 2014-2025
5.8.3 The UK Neuromodulation Devices Market – Political Challenges
5.9 The Spanish Neuromodulation Devices Market: 2014-2025
5.9.1 The Spanish Neuromodulation Devices Market: 2014
5.9.2 The Spanish Neuromodulation Devices Market Forecast: 2014-2025
5.9.3 The Spanish Neuromodulation Devices Market Outlook
5.10 The Irish Neuromodulation Devices Market: 2014-2025
5.10.1 The Irish Neuromodulation Devices Market: 2014
5.10.2 The Irish Neuromodulation Devices Market Forecast: 2014-2025
5.10.3 The Irish Neuromodulation Devices Market Benefiting from-Foreign Investment
5.11 The Brazilian Neuromodulation Devices Market: 2014-2025
5.11.1 The Brazilian Neuromodulation Devices Market: 2014
5.11.2 The Brazilian Neuromodulation Devices Market Forecast: 2014-2025
5.11.3 The Brazilian Neuromodulation Devices Market: Economic and Political Challenges Affecting Prospects
5.12 The Chinese Neuromodulation Devices Market: 2014-2025
5.12.1 The Chinese Neuromodulation Devices Market: 2014
5.12.2 The Chinese Neuromodulation Devices Market Forecast: 2014-2025
5.12.3 The Chinese Neuromodulation Devices Market Forecast: a Wall to Foreign Investment?
5.13 The Indian Neuromodulation Devices Market: 2014-2025
5.13.1 The Indian Neuromodulation Devices Market: 2014
5.13.2 The Indian Neuromodulation Devices Market Forecast: 2014-2025
5.13.3 The Indian Neuromodulation Devices Market: What’s Possible in that Rising Industrial Power?
5.14 The Russian Neuromodulation Devices Market Forecast: 2014-2025
5.14.1 The Russian Neuromodulation Devices Market: 2014
5.14.2 The Russian Neuromodulation Devices Market Forecast: 2014-2025
5.14.3 The Russian Neuromodulation Devices Market Outlook: Foreign Restrictions – Return of an Iron Curtain?
6. Neuromodulation Devices Market: Manufacturers
6.1 Medtronic
6.1.1 Sales and Recent Performance Analysis: 2014
6.1.2 Medtronic International Operations
6.1.3 Medtronic – Neuromodulation Performance
6.1.4 Medtronic – News
6.1.4.1 Medtronic Mergers
6.1.4.2 Expansion into DBS Market
6.1.4.3 Medtronic Products
6.1.5 Medtronic – Market Risk
6.2 Boston Scientific
6.2.1 Sales and Recent Performance Analysis: 2014
6.2.2 Boston Scientific International Operations
6.2.3 Boston Scientific – Neuromodulation Performance
6.2.4 Boston Scientific News
6.2.4.1 Boston Scientific Acquisitions
6.2.4.2 Expansion into DBS Market
6.2.4.3 Boston Scientific Products
6.2.5 Boston Scientific – Market Risk
6.3 St. Jude Medical (SJM)
6.3.1 Sales and Recent Performance Analysis: 2014
6.3.2 SJM International Operations
6.3.3 SJM – Neuromodulation Performance
6.3.4 SJM News
6.3.4.1 SJM Acquisitions
6.3.4.2 SJM Products
6.3.5 SJM – Market Risk
6.4 Cyberonics
6.4.1 Sales and Recent Performance Analysis: 2014
6.4.2 Cyberonics International Operations
6.4.3 Cyberonics – Neuromodulation Performance
6.4.4 Cyberonics News
6.4.4.1 Cyberonics Investments
6.4.4.2 Cyberonics Products
6.4.5 Cyberonics – Market Risk
6.5 Other Companies
6.5.1 Stryker Corporation
6.5.2 Nevro Corp.
6.5.3 SetPoint Medical
6.5.4 Functional Neuromodulation
6.5.5 Neurotherapies Reset
6.5.6 Wiringless Implantable Stretchable Electronics (WISE)
6.5.7 SceneRay
6.5.8 Mindray
7. Qualitative Analysis of the Neuromodulation Devices Market
7.1 SWOT Analysis of the Neuromodulation Devices Market
7.1.1 Strengths of the Market
7.1.1.1 An Ageing Population
7.1.1.2 Alternative Form of Treatment
7.1.1.3 Convenience
7.1.2 Weaknesses
7.1.2.1 Research and Development (R&D)
7.1.2.2 Oligarchic Market
7.1.3 Opportunities in the Neuromodulation Devices Market
7.1.3.1 The Advancement of Research
7.1.3.2 A Shift towards Personalisation
7.1.4 Threats Facing the Neuromodulation Devices Market
7.1.4.1 The Challenge of Regulation
7.2 STEP Analysis of the Neuromodulation Devices Market
7.2.1 Social Factors: The Cost of Living Longer
7.2.2 Technological Developments: The Bionic Man
7.2.3 Economic Pressure: The Price of Health
7.2.4 Political Issues: Government Influences
8. Opinions from Our Industry Survey
8.1 Interview with Spokesman from a Medical Device Company
8.1.1 The Cochlear Implant Market
8.1.2 Cochlear Implant Technology
8.1.3 Products and Competition
8.1.4 Future Cochlear Implant Market
8.2 Interview with Martin Dobelle, Avery Biomedical
8.2.1 The Neuromodulation Devices Market
8.2.2 Phrenic Nerve Stimulation and the Breathing Pacemaker System
8.2.3 Patient Perception and Regulation
8.2.4 Future Projections for the Neuromodulation Devices Market
9. Conclusions of the Study
9.1 DBS and VNS – The Future of the Market
9.2 The US – Still the Largest National Market
9.3 China and India will Lead the Emerging Markets
9.4 Treatment – It’s Personal
9.5 The Neuromodulation Devices R&D Pipeline Remains Strong
9.6 Concluding Remarks
Table 1.1 Forecast Regional and National Neuromodulation Devices: Market Sizes ($bn), Annual Growth (%), CAGRs (%), 2013-2019
Table 1.2 Forecast Regional and National Neuromodulation Devices: Market Sizes ($bn), Annual Growth (%), CAGR (%), 2019-2025
Table 1.3 Currency Exchange Rates: Average Exchange Rate to USD, 2014
Table 3.1 The Global Neuromodulation Devices Markets: Revenue Forecast ($bn), Annual Growth (%), CAGRs (%), 2014-2025
Table 3.2 Neuromodulation Submarket Revenue ($bn) and Market Share (%), 2013, 2019 and 2025
Table 4.1 SCS Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 4.2 The DBS Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 4.3 The VNS Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 4.4 The SNS Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 4.5 The Other Neuromodulation Devices Market: Revenue Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.1 Neuromodulation Devices Market Revenue ($bn) and Market Share (%) by Leading Country, 2013, 2019 and 2025
Table 5.2 The US Neuromodulation Devices Revenue Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.3 The Japanese Neuromodulation Devices Revenue Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.4 The EU Neuromodulation Devices Revenue Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.5 The German Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.6 The French Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.7 The Italian Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.8 The UK Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.9 The Spanish Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.10 The Irish Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.11 The Brazilian Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.12 The Chinese Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.13 The Indian Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 5.14 The Russian Neuromodulation Devices Forecast ($bn), Annual Growth (%) and CAGR (%), 2014-2025
Table 6.1 Medtronic Neuromodulation Revenue ($bn), 2012-2014
Table 6.2 Boston Scientific Neuromodulation Revenue ($bn), 2011-2013
Table 6.3 SJM Neuromodulation Revenue ($bn), 2011-2013
Table 6.4 Cyberonics Neuromodulation Revenue ($bn), 2010-2014
Table 7.1 SWOT Analysis of the Neuromodulation Devices Market, 2014
Table 7.2 STEP Analysis of the Neuromodulation Devices Market, 2014
Table 9.1 National Neuromodulation Market Revenues ($bn) and Market Shares (%), 2013, 2019 and 2025
List of Figures
Figure 1.1 Neuromodulation Devices Market Segmentation, 2014
Figure 3.1 Global Neuromodulation Devices Market Share (%) Segmentation, 2013
Figure 3.2 The Global Neuromodulation Devices Market: Revenue Forecast ($bn), 2014-2025
Figure 3.3 Global Neuromodulation Devices Market Share (%) Segmentation, 2019
Figure 3.4 Global Neuromodulation Devices Market Share (%) Segmentation, 2025
Figure 3.5 Global Neuromodulation Devices Market: Drivers and Restraints, 2014-2025
Figure 4.1 SCS Devices Market Share (%) Segmentation, 2014
Figure 4.2 SCS Devices Revenue Forecast ($bn), 2014-2025
Figure 4.3 DBS Devices Market Share (%) Segmentation, 2014
Figure 4.4 DBS Devices Revenue Forecast ($bn), 2014-2025
Figure 4.5 VNS Devices Market Share (%) Segmentation, 2014
Figure 4.6 VNS Devices Revenue Forecast ($bn), 2014-2025
Figure 4.7 SNS Devices Market Share (%) Segmentation, 2014
Figure 4.8 SNS Devices Revenue Forecast ($bn), 2014-2025
Figure 4.9 Other Neuromodulation Devices Market Share (%) Segmentation, 2014
Figure 4.10 Other Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.1 Developed National Markets: Drivers and Restraints, 2014-2025
Figure 5.2 Emerging National Markets: Drivers and Restraints, 2014-2025
Figure 5.3 US Global Neuromodulation Devices Market Share (%), 2014
Figure 5.4 The US Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.5 Japanese Global Neuromodulation Devices Market Share (%), 2014
Figure 5.6 The Japanese Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.7 The EU Global Neuromodulation Devices Market Share (%), 2014
Figure 5.8 The EU Regional Neuromodulation Devices Market Shares (%), 2014
Figure 5.9 The EU Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.10 The German Neuromodulation Devices Market Share (%) within the EU, 2014
Figure 5.11 German Global Neuromodulation Devices Market Share (%), 2014
Figure 5.12 The German Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.13 The French Neuromodulation Devices Market Share (%) within the EU, 2014
Figure 5.14 French Global Neuromodulation Devices Market Share (%), 2014
Figure 5.15 The French Neuromodulation Device Revenue Forecast ($bn), 2014-2025
Figure 5.16 The Italian Neuromodulation Devices Market Share (%) within the EU, 2014
Figure 5.17 Italian Global Neuromodulation Devices Market Share (%), 2014
Figure 5.18 The Italian Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.19 The UK Neuromodulation Devices Market Share (%) within the EU, 2014
Figure 5.20 UK Global Neuromodulation Devices Market Share (%), 2014
Figure 5.21 The UK Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.22 The Spanish Neuromodulation Devices Market Share (%) within the EU, 2014
Figure 5.23 Spanish Global Neuromodulation Devices Market Share (%), 2014
Figure 5.24 Spanish Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.25 The Irish Neuromodulation Devices Market Share (%) within the EU, 2014
Figure 5.26 Irish Global Neuromodulation Devices Market Share (%), 2014
Figure 5.27 Irish Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.28 Brazilian Global Neuromodulation Devices Market Share (%), 2014
Figure 5.29 Brazilian Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.30 Chinese Global Neuromodulation Devices Market Share (%), 2014
Figure 5.31 Chinese Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.32 Indian Global Neuromodulation Devices Market Share (%), 2014
Figure 5.33 Indian Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 5.34 Russian Global Neuromodulation Devices Market Share (%), 2014
Figure 5.35 Russian Neuromodulation Devices Revenue Forecast ($bn), 2014-2025
Figure 6.1 Medtronic Revenue ($bn), 2010-2014
Figure 6.2 Medtronic Operating Sectors (%), 2014
Figure 6.3 Medtronic Sales Shares (%), 2014
Figure 6.4 Medtronic Geographical Sales Shares (%), 2014
Figure 6.5 Medtronic Neuromodulation Revenue Shares (%) within Restorative Therapies, 2014
Figure 6.6 Medtronic Neuromodulation Revenue ($bn), 2012-2014
Figure 6.7 Boston Scientific Revenue ($bn), 2009-2013
Figure 6.8 Boston Scientific Operating Sectors (%), 2014
Figure 6.9 Boston Scientific Sector Shares (%), 2014
Figure 6.10 Boston Scientific World Sales Shares (%), 2013
Figure 6.11 Boston Scientific Geographical Sales Shares (%), 2013
Figure 6.12 Boston Scientific Neuromodulation Revenue ($bn), 2011-2013
Figure 6.13 Boston Scientific Neuromodulation Revenue Shares (%) within Med-Surgical Sector, 2014
Figure 6.14 St. Jude Medical Revenue ($bn), 2009-2013
Figure 6.15 St. Jude Medical Operating Sectors (%), 2014
Figure 6.16 St. Jude Medical World Sales Shares (%), 2013
Figure 6.17 St. Jude Medical Geographical Sales Shares (%), 2013
Figure 6.18 St. Jude Medical Revenues ($bn), 2011-2013
Figure 6.19 St. Jude Medical Sales Distribution ($bn), Q1 2014 to Q3 2014
Figure 6.20 St. Jude Medical Neuromodulation Revenue ($bn), 2011-2013
Figure 6.21 St. Jude Medical Neuromodulation Devices Quarterly Analysis ($bn), 2013-2014
Figure 6.22 Cyberonics Revenue ($bn), 2010-2014
Figure 6.23 Cyberonics World Sales Shares (%), 2014
Figure 6.24 Cyberonics Sales Distribution ($bn), 2012-2014
Figure 9.1 World Neuromodulation Devices Market Share (%) Segmentation, 2025
【レポートのキーワード】
神経調節、医療装置(デバイス)、脊髄刺激療法(SCS)、脳深部刺激療法(DBS)、迷走神経刺激療法(VNS)、仙骨神経刺激療法(SNS)